Advertisement

The Scientist

» pharmaceuticals

Most Recent

image: Top GSK Scientist Fired Over Paper

Top GSK Scientist Fired Over Paper

By | June 19, 2013

The head of GlaxoSmithKline’s Shanghai neurodegenerative-disease research unit is axed after irregularities are uncovered in a 2010 paper he published.

0 Comments

image: Release of Drug Data Blocked

Release of Drug Data Blocked

By | May 2, 2013

A court ruling that stops the European Medicines Agency from releasing data from two US companies calls into question the agency’s push for transparency.

0 Comments

image: AstraZeneca Downsizing R&D Staff

AstraZeneca Downsizing R&D Staff

By | March 19, 2013

Positions for 1,600 scientists at the pharmaceutical company will be eliminated globally.

0 Comments

image: FDA Reform to Boost US Economy?

FDA Reform to Boost US Economy?

By | March 5, 2013

Two experts propose replacing Phase 3 trials with smaller, faster alternatives and post-market surveillance to invigorate the pharmaceutical industry.

0 Comments

image: Antibody-Drug Combo Approved

Antibody-Drug Combo Approved

By | February 25, 2013

The FDA approves an antibody-drug conjugate that effectively treats a certain type of advanced breast cancer with fewer side effects than previous drugs.

0 Comments

image: Drugged Fish Act Different

Drugged Fish Act Different

By | February 14, 2013

A psychiatric drug in the water can cause perch to be less social, more voracious hunters.

0 Comments

image: Can Magnesium Magnify Brain Power?

Can Magnesium Magnify Brain Power?

By | October 29, 2012

A magnesium supplement thought to improve brain functioning gets a small clinical trial.

0 Comments

image: Uncloaking Clinical Trials

Uncloaking Clinical Trials

By | October 17, 2012

Glaxo­SmithKline will share long-sought, raw trial data—but access will be tightly controlled.  

0 Comments

image: Mission: Possible

Mission: Possible

By | October 1, 2012

Cooperation, not competition, is the way forward.

1 Comment

image: Drugmakers Question FDA's Integrity

Drugmakers Question FDA's Integrity

By | September 26, 2012

Pharmaceutical and biotech companies ask the US Food and Drug Administration to ensure the independence of a third-party audit of its new drug program.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Cisbio
Cisbio
Advertisement
The Scientist
The Scientist